We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Long-acting injectable formulations of paliperidone, ...

Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported during a poster presentation at ...

April 12, 2011 — The US Food and Drug Administration (FDA) has approved paliperidone (Invega; Ortho-McNeil-Janssen Pharmaceuticals) for the treatment of schizophrenia in adolescent patients aged 12 to ...

With respect to tolerability concerns with the recommended paliperidone palmitate initiation dosing, this study did not reveal unexpected adverse events or high rates of specific adverse events in the ...

Please provide your email address to receive an email when new articles are posted on . Paliperidone palmitate appeared to benefit Black patients with recent-onset schizophrenia or schizophreniform ...

Learn everything you need to know about Paliperidone Palmitrate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, ...

Paliperidone 3 mg, 6 mg, 9 mg; extended-release tabs. Paliperidone is the major active metabolite of risperidone. Although the mechanism of action of this atypical antipsychotic is unknown, the ...

PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in ...

Oral- 6 mg/day in the morning. It may be increased in some patients if needed. Maximum recommended dose is 12 mg/day.

If you have schizophrenia or schizoaffective disorder, your doctor might suggest Invega as a treatment option for you. Knowing the possible side effects of Invega can help you and your doctor decide ...